identif
viral
bcell
epitop
import
select
peptid
inclus
subunit
vaccin
develop
virusspecif
serolog
test
understand
interact
antibodi
virus
molecular
level
bcell
epitop
often
determin
unequivoc
xray
analys
antibodyantigen
complex
techniqu
howev
timeconsum
altern
strategi
develop
identifi
epitop
articl
provid
overview
approach
current
avail
map
imit
bcell
epitop
viral
infect
usual
result
product
specif
glycoprotein
antibodi
assembl
four
constant
four
variabl
polypeptid
chain
host
blymphocyt
variabl
region
antibodi
form
two
receptor
paratop
abl
bind
predominantli
via
hydrogen
bond
discret
region
epitop
antigen
determin
foreign
agent
often
promot
elimin
bodi
whilst
concis
definit
constitut
epitop
contenti
issu
purpos
paper
proteinaci
epitop
presum
compris
amino
acid
antigen
involv
bond
format
residu
correspond
paratop
also
conflict
view
upon
paratop
actual
gain
access
bind
epitop
review
van
regenmortel
believ
interact
may
view
lockandkey
system
wherebi
paratop
recogn
fix
region
antigen
directli
complementari
shape
chemic
characterist
other
envisag
inducedfit
model
antibodi
bind
depend
upon
slight
movement
side
chain
backbon
antigen
accommod
antibodi
ie
akin
adapt
shape
necessari
posit
hand
insid
glove
clear
natur
infect
vast
major
antigenspecif
antibodi
direct
conformationdepend
assembl
epitop
present
nativ
stcture
aver
et
al
epitop
depend
upon
interandor
intramolecular
interact
permit
distant
term
linear
sequenc
amino
acid
come
close
proxim
form
antigen
determin
howev
equal
appar
anoth
type
epitop
also
exist
bear
much
closer
resembl
protein
primari
structur
linear
continu
epitop
consist
five
eight
contigu
residu
protein
amino
acid
sequenc
divis
conformationdepend
linear
epitop
may
somewhat
artifici
case
antibodi
induc
intact
protein
sinc
linear
epitop
recogn
may
repres
constitu
part
coormationdependeni
epitop
antibodi
linear
epitop
consider
valu
easi
prepar
mani
worker
use
denatur
protein
synthet
peptid
ie
essenti
fsr
amino
acid
dna
sequenc
need
order
identifi
epitop
c
abil
mimic
conformationdepend
l
linear
eptitop
whilst
map
techniqu
produc
defin
epitop
techniqu
depend
upon
deriv
random
deduct
epitop
may
identifi
sequenc
actual
present
origin
protein
immunogen
linear
immunogen
produc
specif
antisera
monoclon
antibodi
mab
experiment
anim
antibodi
use
molecular
probe
sometim
biolog
activ
identif
linear
immunogen
induc
neutral
antibodi
intact
viru
particl
may
consider
interest
concern
design
subunit
viral
vaccin
current
sequenc
data
medic
import
antigen
accru
hitherto
unpreced
rate
rel
easi
produc
recombin
dnaderiv
antigen
correspond
antibodi
establish
method
epitop
map
xray
crystallographi
suffer
rel
slow
accordingli
techniqu
molecular
biolog
organ
chemistri
util
develop
strategi
identifi
antigen
determin
approach
current
bias
toward
identif
proteinaci
epitop
virus
due
extens
preexist
knowledg
protein
chemistri
limit
size
viral
genom
facilit
rapid
sequenc
deduct
potenti
antigen
techniqu
map
epitop
review
subdivid
applic
three
scenario
name
nativ
viral
antigen
character
readili
avail
known
unavail
complet
unknown
rel
merit
differ
epitop
map
method
describ
summar
tabl
structur
conformationdepend
epitop
often
elucid
certainti
xray
crystallograph
studi
antigenfab
fab
fragment
antigen
bind
antibodi
complex
laver
et
al
approach
permit
detail
analys
antigenantibodi
interact
use
solv
threedimension
structur
idiotypeantiidiotyp
complex
bentley
et
al
epitop
rotaviru
prasad
et
al
howev
xray
crystallographi
expens
slow
restrict
special
depart
alway
provid
concis
result
exampl
neutral
epitop
footandmouth
diseas
viru
could
clearli
establish
techniqu
parri
et
al
furthermor
occas
antigenfab
crystal
prove
difficult
imposs
prepar
despit
problem
xray
crystallographi
comparison
reduct
epitop
map
method
believ
provid
accur
view
epitopeparatop
interact
sinc
permit
topograph
local
epitop
context
intact
nativ
antigen
infecti
agent
investig
abil
mutat
exposur
neutral
antibodi
vitro
vivo
rational
behind
approach
nucleic
acid
chang
result
amino
acid
code
differ
escap
mutant
origin
isol
contribut
epitop
recogn
neutral
form
drapeau
et
al
lehning
boehring
x
amino
acid
nonenzym
cleavag
antibodi
method
particularli
use
studi
rna
virus
proofread
function
result
greater
variat
rna
genom
whilst
dna
virus
may
similar
propens
mutat
chang
correct
interpret
result
may
conceiv
complic
occurr
random
mutat
site
form
part
neutral
epitop
nevertheless
techniqu
success
use
defin
neutral
epitop
polioviru
minor
et
al
minor
et
al
footandmouth
diseas
viru
xie
et
al
avian
bronchiti
viru
kant
et
al
protein
antigen
dissect
use
enzym
cut
protein
specifi
amino
acid
residu
eg
tabl
produc
fragment
whose
molecular
weight
calcul
protein
amino
acid
sequenc
subject
result
polypeptid
polyacrylamid
gel
electrophoresi
western
blot
epitop
local
intact
protein
appar
molecular
weight
immunoreact
fragment
analys
proteolyt
cleavag
product
led
identif
p
prokaryot
e
eukaryot
express
system
epitop
l
predominantli
linear
c
conformationdepend
vlp
viruslik
protein
structur
corn
variou
kit
vector
avail
commerci
common
plasmid
express
includ
pex
produc
pgalactosidas
fusion
protein
path
produc
tryptophanesynthetas
fusion
protein
pgex
produc
glutathionestrnsferas
fusion
protein
ebv
epsteinbarr
viru
bpv
bovin
papillomaviru
groupspecif
antigen
determin
major
capsid
protein
group
rotavirus
kohli
et
al
howev
note
see
similar
epitop
map
techniqu
limit
measur
actual
crossreact
antibodi
complet
protein
polypeptid
fragment
pure
assumpt
fragment
assum
structur
even
similar
adopt
context
posit
within
intact
protein
dna
rna
code
otherwis
unavail
even
unknown
protein
antigen
usual
amplifi
clone
sequenc
recombin
protein
protein
subregion
may
construct
use
epitop
map
studi
strike
exampl
effect
strategi
isol
character
develop
serolog
test
previous
unidentifi
pathogen
viru
name
hepat
c
choo
et
al
alter
et
al
nucleic
acid
code
protein
clone
one
varieti
prokaryot
eukaryot
express
vector
mani
avail
commerci
tabl
easili
manipul
commonli
use
system
involv
express
protein
e
coli
recombin
plasmid
express
system
advantag
larg
quantiti
recombin
protein
prepar
quickli
cheapli
howev
system
may
prove
appropri
exampl
suspect
epitop
may
influenc
posttransl
modif
glycosyl
phosphoryl
myristil
case
eukaryot
express
via
commerci
avail
baculovirusinsect
cell
yeast
kit
permit
product
high
level
posttranscript
modifi
viral
protein
sometim
selfassembl
form
viruslik
particl
carter
et
al
kirnbauer
et
al
panel
subregion
protein
antigen
produc
restrict
endonucleas
digest
code
dna
order
map
bcell
epitop
recombin
protein
subregion
use
explain
serolog
differ
strain
human
cytomegaloviru
basgoz
et
al
altern
proteolyt
cleavag
employ
determin
posit
epitop
though
may
complic
fusion
protein
use
anoth
approach
digest
antigen
code
dna
exonucleas
select
cleav
nucleotid
terminu
remov
sampl
interv
prior
insert
plasmid
permit
product
panel
polypeptid
vari
length
success
truncat
carboxyl
terminu
use
screen
immunoreact
region
dna
code
region
sequenc
epitop
determin
use
delet
mutant
protein
human
rhinoviru
result
identif
neutral
epitop
kern
et
al
rudimentari
knowledg
organ
chemistri
possibl
construct
small
peptid
correspond
subregion
protein
antigen
use
fmot
thoc
chemistri
peptid
often
synthes
seri
nest
amino
acid
overlap
encompass
entir
protein
investig
peptid
use
antigen
enzymelink
immunosorb
assay
eia
deduc
epitop
approach
expens
use
defin
typerestrict
epitop
major
coat
protein
human
papillomaviru
cason
et
al
develop
geysen
et
al
pin
system
pepscan
revolution
form
epitop
map
permit
rapid
cheap
construct
hundr
peptid
briefli
peptid
construct
polyethylen
pin
use
situ
antigen
eia
whilst
peptid
gener
consid
primarili
valu
identif
linear
antigen
determin
recent
work
shown
aggreg
peptid
may
also
abl
imit
conformationdepend
epitop
rao
et
al
identifi
epitop
rel
contribut
amino
acid
antibodi
bind
investig
synthes
artifici
mutant
peptid
hexamer
epitop
set
peptid
may
produc
constitu
amino
acid
sequenti
replac
remain
possibl
amino
acid
whilst
keep
five
amino
acid
unchang
geysen
et
al
similarli
minimum
bind
site
antibodi
identifi
creat
panel
peptid
sequenti
truncat
amino
andor
carboxyl
terminu
synthet
peptid
employ
local
antigen
determin
recogn
neutral
mab
footandmouth
diseas
viru
meloen
et
al
rhinoviru
sherri
et
al
human
immunodefici
viru
papsidero
et
al
murin
coronavirus
luytj
et
al
typerestrict
epitop
human
papillomaviru
type
cason
et
al
whilst
peptid
map
techniqu
particularli
use
identifi
epitop
recogn
mab
polyclon
antisera
deriv
hyperimmun
anim
applic
technolog
identifi
epitop
recogn
antibodi
human
sera
often
prove
problemat
due
high
level
antibodi
bind
peptid
per
se
synthet
peptid
select
region
protein
also
use
immunogen
rais
epitopedefin
antibodi
antipeptid
probe
use
investig
express
biolog
function
particular
epitop
nativ
protein
virion
method
use
studi
neutral
activ
mab
select
peptid
subregion
human
immunodefici
viru
langedijk
et
al
antibodi
certain
linear
bcell
epitop
neutral
activ
footandmouth
diseas
viru
et
al
influenza
viru
muller
et
al
bovin
papillomaviru
cason
et
al
situat
aris
mab
interest
obtain
use
crude
mixtur
protein
cell
homogen
clinic
lesion
whilst
origin
immunogen
protein
may
unknown
epitop
map
strategi
devis
independ
prior
knowledg
antigen
characterist
practic
techniqu
involv
either
present
larg
number
peptid
shape
antibodi
studi
deriv
epitop
mimic
mimotop
process
iter
spectrum
shape
capabl
act
epitop
limit
size
sinc
definit
must
abl
fit
correspond
paratop
repertoir
shape
reduc
host
downregul
autoreact
paratop
also
acquisit
toler
determin
despit
restraint
individu
anim
still
thought
capabl
produc
specif
antibodi
uniqu
epitop
roitt
et
al
note
major
antibodi
usual
direct
conformationdepend
epitop
howev
reason
believ
random
peptid
unabl
adopt
shape
similar
even
ident
conformationdepend
linear
epitop
approxim
number
residu
epitop
contact
paratop
six
amino
acid
thu
one
creat
randomsequ
hexamer
peptid
librari
compris
amino
acid
code
dna
ie
lstereoisom
x
uniqu
amino
acid
sequenc
may
gener
assum
sequenc
form
uniqu
threedimension
shape
random
hexamer
peptid
may
mimic
approxim
epitop
recogn
bcell
repertoir
approach
may
advantag
sinc
may
also
possibl
mimic
nonproteinaci
epitop
shown
antibodi
capabl
reproduc
bind
dipeptid
bank
antigen
shape
prepar
construct
peptid
first
two
amino
acid
hexam
defin
construct
peptid
j
casonjourn
virolog
method
contain
possibl
amino
acid
combin
first
two
posit
whilst
remain
four
posit
synthes
use
equimolar
mixtur
amino
acid
panel
peptid
screen
use
antibodi
investig
reactiv
defin
dimer
sequenc
retain
third
amino
acid
posit
vari
amino
acid
remain
residu
produc
equimolar
mix
amino
acid
rescreen
deduct
appropri
third
amino
acid
variant
fourth
posit
test
one
select
complet
optimalbind
hexamer
epitop
deriv
houghten
et
al
random
pentamer
peptid
sequenc
synthes
onto
small
resin
bead
bead
coat
singl
peptid
speci
achiev
coupl
amino
acid
cystein
omit
elimin
disulphid
crosslink
individu
aliquot
bead
aliquot
mix
redivid
sampl
second
amino
acid
coupl
process
repeat
pentapeptid
librari
complet
way
librari
x
random
peptid
produc
method
advantag
individu
bead
bear
singl
peptid
speci
antigen
peptideco
bead
identifi
local
colour
reaction
eia
upon
microscop
examin
immunoreact
bead
retriev
wash
free
antibodi
urea
amino
acid
sequenc
antigen
determinantantigen
mimic
identifi
use
microsequenc
lam
et
al
random
peptid
may
also
express
use
fd
vector
relat
famili
filament
bacteriophag
dna
encod
peptid
introduc
two
domain
protein
smith
near
terminu
parmley
smith
short
oligonucleotid
encod
peptid
sequenc
insert
region
express
phage
surfac
insert
random
oligonucleotid
code
peptid
sequenc
amino
acid
possibl
gener
librari
recombin
phage
express
small
random
amino
acid
sequenc
surfac
scott
smith
cwirla
et
al
sampl
individu
coloni
transfer
nitrocellulos
sheet
test
antibodi
investig
dotblot
assay
coloni
express
appropri
epitop
identifi
dna
sequenc
amino
acid
sequenc
deriv
potenti
problem
associ
random
peptidebas
approach
describ
uncommon
antibodi
bind
epitop
one
origin
rais
phenomenon
known
heterospecif
heteroclit
makela
almoudal
et
al
harper
et
al
henc
possibl
identifi
antigen
determin
whose
amino
acid
sequenc
occur
origin
protein
immunogen
furthermor
techniqu
prove
popular
present
difficult
assess
effect
actual
note
antibodi
bind
reproduc
dipeptid
thu
possibl
select
possibl
dipeptid
one
dimer
best
recogn
mab
increas
spectrum
antigen
shape
imit
given
peptid
unnatur
amino
acid
ie
ostereoisom
also
includ
identifi
dipeptid
epitop
four
possibl
combin
land
unnatur
stereoisom
amino
acid
dipeptid
test
sequenc
exhibit
highest
mab
bind
select
deriv
dipeptid
test
addit
possibl
dor
lamino
acid
ad
carboxyl
amino
terminu
without
alanin
spacer
determin
optim
third
fourth
residu
result
peptid
select
mimotop
geysen
et
al
geysen
et
al
epitop
mimick
approach
prove
popular
amongst
experamentalist
valu
henc
difficult
evalu
articl
provid
overview
approach
current
avail
identif
bcell
epitop
present
newer
reduct
bcell
map
techniqu
appear
effect
map
epitop
recogn
mab
polyclon
antisera
rais
linear
proteinaci
epitop
obviou
limit
whilst
random
peptid
mimotop
approach
may
valu
deriv
mimic
conformationdepend
epitop
new
techniqu
requir
form
antigen
determin
map
accuraci
one
possibl
answer
could
involv
gener
larg
number
mutant
protein
local
amino
acid
crucial
antibodi
bind
advanc
molecular
model
techniqu
use
comput
graphic
may
also
enabl
identif
antigen
determin
sequenc
protein
recogn
dna
sequenc
mab
paratop
anoth
area
remain
rel
unexplor
map
epitop
nonproteinac
antigen
doubt
progress
parallel
advanc
sugar
lipid
biochemistri
paradox
peptid
strategi
map
bcell
epitop
describ
realiz
appropri
identif
tcell
epitop
sinc
consist
short
peptid
rather
conformationdepend
structur
inde
pepscan
method
modifi
permit
cleavag
peptid
polyethylen
pin
use
determin
thelper
tcytotox
cell
determin
foreign
protein
